1,1,1,3,3,3-Hexafluoropropane
| Common Name: |
1,1,1,3,3,3-Hexafluoropropane |
| IUPAC Name: |
1,1,1,3,3,3-hexafluoropropane |
| Molecular Formula: |
C3H2F6 |
| SMILES: |
C(C(F)(F)F)C(F)(F)F |
| Inchi: |
1S/C3H2F6/c4-2(5,6)1-3(7,8)9/h1H2 |
| Inchi Key: |
NSGXIBWMJZWTPY-UHFFFAOYSA-N |
| Cas No: |
690-39-1 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
3 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
3 |
| Name |
Value |
| Molecular Weight (g/mol) |
152.04 |
| Mass (g/mol) |
152.006 |
| Molar Refractivity |
16.92 |
| Net Charge |
|
| HBD |
|
| HBA |
6 |
| Rt Bonds |
2 |
| Rings |
|
| TPSA |
0.00 |
| Hetero Atoms |
6 |
| Heavy Atoms |
9 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
-94.2 |
| Boiling Point (°C@760.00mm Hg) |
-1.1 |
| Vapor Pressure (mmHg@25.00 °C) |
|
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
1.00 |
| LogP |
2.501 |
| iLOGP |
1.29 |
| XLOGP3 |
2.81 |
| WLOGP |
5.02 |
| MLOGP |
2.60 |
| ESOL Log S |
-2.42 |
| ESOL Solubility (mg/ml) |
0.577 |
| ESOL Solubility (mol/l) |
0.004 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-2.47 |
| Ali Solubility (mg/ml) |
0.52 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.04 |
| Silicos-IT Solubility (mg/ml) |
1.39 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
Low |
| BBB Permeable |
0 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.23 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
-0.035 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.742 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
